Skip to main content

Advertisement

SpringerLink
Log in

Methylphenidate does not increase ethanol consumption in a rat model for attention-deficit hyperactivity disorder—the spontaneously hypertensive rat

  • Original Paper
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

Attention-deficit hyperactivity disorder (ADHD) is a behavioural disorder that has been suggested to result from disturbances in the dopaminergic system of the brain. The most effective drugs used to treat ADHD are the psychostimulants, methylphenidate and amphetamine. They block dopamine transporters and increase dopamine release, thereby increasing the extracellular concentration of dopamine and altering dopamine signaling. Drugs of abuse, such as cocaine, also block dopamine transporters, which raises the concern that treatment of children with ADHD with psychostimulants might increase their susceptibility to drug addiction. The present study was aimed at investigating whether treatment with methylphenidate at an early stage of development increased preference for ethanol in a widely used rat model for ADHD, the spontaneously hypertensive rat (SHR). SHR display the three major characteristics of ADHD (hyperactivity, impulsivity, poor sustained attention) compared to their progenitor Wistar-Kyoto (WKY) rat strain. Ethanol increased locomotor activity of SHR slightly more than WKY when injected intraperitoneally (0.6 g/kg). SHR also spent more time in the inner zone of the open field than WKY, consistent with SHR being less anxious than WKY. When given free access to ethanol-containing solutions of increasing concentration, SHR consumed less ethanol than WKY. Treatment with methylphenidate at an early age (P21 to P35) did not alter ethanol consumption in adult SHR or WKY, suggesting that it does not increase susceptibility to ethanol addiction in these rats. In vitro superfusion studies further demonstrated that preadolescent methylphenidate treatment did not have long-term effects on dopamine release in adult SHR and WKY striatum. A major finding of this study is the fact that methylphenidate treatment did not increase alcohol use in SHR.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Bailey CP, O’Callaghan MJ, Croft AP, Manley SJ, Little HJ (2001) Alterations in mesolimbic dopamine function during the abstinence period following chronic alcohol consumption. Neuropharmacology 41:989–999

    Article  PubMed  CAS  Google Scholar 

  • Brandon CL, Marinelli M, Baker LK, White FJ (2001) Enhanced reactivity and vulnerability to cocaine following low dose exposure to methylphenidate in adolescent rats. Neuropsychopharmacology 25:651–661

    Article  PubMed  CAS  Google Scholar 

  • Carlezon WA, Mague SD, Andersen SL (2003) Enduring behavioral effects of early exposure to methylphenidate in rats. Biol Psychiatry 54:1330–1337

    Article  PubMed  CAS  Google Scholar 

  • Cierpial MA, Shasby DE, Murphy CA, Borom AH, Stewart RE, Swithers SE, McCarty R (1989) Open-field behavior of spontaneously hypertensive and Wistar-Kyoto normotensive rats: effects of Reciprocal Cross-Fostering. Behav and Neural Biol 51:203–210

    Article  CAS  Google Scholar 

  • Da Silva GE, Ramos A, Takahashi RN (2004) Comparison of voluntary ethanol intake by two pairs of rat lines used as genetic models of anxiety. Brazil Med Biol Res 37:1511–1517

    Article  Google Scholar 

  • Da Silva GE, Vendruscolo LF, Takahashi RN (2005) Effects of ethanol on locomotor and anxiety-like behaviors and the acquisition of ethanol intake in Lewis and spontaneously hypertensive rats. Life Sci 77:693–706

    Article  PubMed  Google Scholar 

  • Dresel S, Krause J, Krause KH, LaFougere C, Brinkbäumer K, Kung HF, Hahn K, Tatsch K (2000) Attention deficit hyperactivity disorder: binding of [99mTc] TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Euro Nucl Med 27:1518–1524

    Article  CAS  Google Scholar 

  • Elia J, Ambrosini PJ, Rapoport JL (1999) Treatment of attention deficit-hyperactivity disorder. N Engl J Med 340:780–788

    Article  PubMed  CAS  Google Scholar 

  • Gatley SJ, Volkow ND, Grifford AN, Fowler JS, Dewey SL, Ding YS, Logon J (1999) Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans. Psychopharmacology 146:93–100

    Article  PubMed  CAS  Google Scholar 

  • Gayton O, Yang P, Swann A, Dafny N (2000) Diurnal differences in sensitization to methylphenidate. Brain Res 864:24–39

    Article  Google Scholar 

  • Kirouac GJ, Ganguly PK (1992) Up-regulation of dopamine receptors in the brain of the spontaneously hypertensive rat: an autoradiographic analysis. Neuroscience 52:135–141

    Article  Google Scholar 

  • Kollins SH (2003) Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient. J Clin Psychiatry 64:14–18

    Article  PubMed  CAS  Google Scholar 

  • Kuczenski R, Segal DS (2005) Stimulant action in rodents: implications for attention-deficit/ hyperactivity disorder treatment and potential substance abuse. Biol Psychiatry 57:1391–1396

    Article  PubMed  CAS  Google Scholar 

  • Narahashi T, Aistrup GL, Marszalec W, Nagata K (1999) Neuronal nicotinic acetylcholine receptors: a new target site for ethanol. Neurochem Internat 35:131–141

    Article  CAS  Google Scholar 

  • Nestby P, Vanderchuuren LJMJ, De Vries TJ, Mulder AH, Wardeh G, Hogenboom F, Schoffelmeer ANM (1999) Unrestricted free-choice ethanol self-administration in rats causes long-term neuroadaptations in the nucleus accumbens and caudate putamen. Psychopharmacology 141:307–314

    Article  PubMed  CAS  Google Scholar 

  • Okamoto K, Aoki K (1963) Development of a strain of spontaneously hypertensive rats. Jpn Circ J 27:282–293

    Article  PubMed  CAS  Google Scholar 

  • Paxinos G, Watson C (2005) The rat brain in stereotaxic coordinates, 5th edn. Elsevier Academic, New York

    Google Scholar 

  • Richelson E, Pfenning M (1984) Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur J Pharmacol 104:227–86

    Article  Google Scholar 

  • Rosa-Neto P, Lou HC, Cumming P, Pryds O, Karrebaek H, Lunding J, Gjedde A (2005) Methylphenidate- evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder. NeuroImage 25:868–876

    Article  PubMed  Google Scholar 

  • Russell V, de Villiers A, Sagvolden T, Lamm M, Taljaard J (1995) Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder—the spontaneously hypertensive rat. Brain Res 676:343–351

    Article  PubMed  CAS  Google Scholar 

  • Russell VA, Lamm MC, de Villiers AD, Reyneke L, Taljaard JJF (1996) [3H] dopamine and [14C] acetylcholine release from rat prefrontal cortex, nucleus accumbens and caudate-putamen slices. Neurosci Prot 96-060-05-01-18

  • Russell VA, de Villiers A, Sagvolden T, Lamm M, Taljaard J (1998) Differences in electrically-, ritalin and D-amphetamine-stimulated release of [3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of attention-deficit hyperactivity disorder. Behav Brain Res 94:163–171

    Article  PubMed  CAS  Google Scholar 

  • Russell VA, de Villiers AS, Sagvolden T, Lamm MCL, Taljaard JJF (2000) Methylphenidate affects striatal dopamine differently in an animal model for attention-deficit/hyperactivity disorder—the spontaneously hypertensive rat. Brain Res Bull 53:187–192

    Article  PubMed  CAS  Google Scholar 

  • Russell VA, Sagvolden T, Johansen EB (2005) Animal models of attention-deficit hyperactivity disorder. Behav Brain Funct 1:1–17

    Article  Google Scholar 

  • Sagvolden T (2000) Behavioural validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci Biobehav Rev 24:31–39

    Article  PubMed  CAS  Google Scholar 

  • Sagvolden T, Russell VA, Aase H, Johansen EB, Farshbaf M (2005) Rodent Models of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1239–1247

    Article  PubMed  Google Scholar 

  • Seeman P, Madras B (2002) Methylphenidate elevates resting dopamine which lowers the impulse-triggered release of dopamine: a hypothesis. Behav Brain Res 130:70–83

    Article  Google Scholar 

  • Söderpalm B, Ericson M, Olausson P, Blomqvist O, Engel JA (2000) Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol. Behav Brain Res 113:85–98

    Article  PubMed  Google Scholar 

  • Stromberg MF, Volpicelli JR, O’Brian CP (1998) Effects of naltrexone administered repeatedly across 30 or 60 days on ethanol consumption using a limited access procedure in the rat. Alcohol Clin Exp Res 22:2186–2191

    Article  PubMed  CAS  Google Scholar 

  • Sue D, Sue DW, Sue S (2000) Disorders of childhood. Understanding abnormal behaviour, 6th edn. Houghton Mifflin Company, New York, pp 478–515

    Google Scholar 

  • Valenzuela CF (1997) Alcohol neurotransmitter interactions. Alcohol Health Res World 21:144–148

    PubMed  CAS  Google Scholar 

  • Volkow ND, Insel TR (2003) What are the long-term effects of methylphenidate treatment? Biol Psychiatry 54:1307–1309

    Article  PubMed  Google Scholar 

  • Volkow ND, Wang GJ, Fowler JS, Logan J, Gerasimov M, Maynard L, Ding YS, Gatley SJ, Grifford A, Franceschi D (2001) Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. Neuroscience 21:1–5

    Google Scholar 

  • Wheeler TL, Eppolito AK, Smith LN, Huff TB, Smith RF (2007) A novel method for oral stimulant administration in the neonate rat and similar species. J Neurosci Methods 159:282–285

    Article  PubMed  CAS  Google Scholar 

  • Wilens TE, Faraone SV, Biederman J, Gunawardene S (2003) Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 111:179–185

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the Medical Research Council of South Africa and the University of Cape Town. The authors wish to thank Mr Leander Bindewald and Mr Letlhogonolo Selaledi for technical assistance.

Author information

Authors and Affiliations

  1. Department of Human Biology, Faculty of Health Sciences, University of Cape Town, Observatory, 7925, South Africa

    Heleen Suzanne Soeters, Fleur Margaret Howells & Vivienne Ann Russell

Authors
  1. Heleen Suzanne Soeters
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fleur Margaret Howells
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vivienne Ann Russell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vivienne Ann Russell.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Soeters, H.S., Howells, F.M. & Russell, V.A. Methylphenidate does not increase ethanol consumption in a rat model for attention-deficit hyperactivity disorder—the spontaneously hypertensive rat. Metab Brain Dis 23, 303–314 (2008). https://doi.org/10.1007/s11011-008-9098-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-008-9098-1

Keywords

Search

Navigation